Matti Jubouri

ORCID: 0000-0001-6725-6164
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Aortic Disease and Treatment Approaches
  • Aortic aneurysm repair treatments
  • Cardiac Valve Diseases and Treatments
  • Cardiac, Anesthesia and Surgical Outcomes
  • Infectious Aortic and Vascular Conditions
  • Cardiac Structural Anomalies and Repair
  • Vascular Procedures and Complications
  • Congenital Heart Disease Studies
  • Cardiac Arrest and Resuscitation
  • Hip and Femur Fractures
  • Vascular anomalies and interventions
  • Trauma Management and Diagnosis
  • Renal and Vascular Pathologies
  • Mechanical Circulatory Support Devices
  • Cardiovascular and Diving-Related Complications
  • Frailty in Older Adults
  • Infective Endocarditis Diagnosis and Management
  • Cardiovascular Issues in Pregnancy
  • Diversity and Career in Medicine
  • Cardiovascular Function and Risk Factors
  • History of Medical Practice
  • Trauma, Hemostasis, Coagulopathy, Resuscitation
  • Reconstructive Surgery and Microvascular Techniques
  • Dental Education, Practice, Research
  • Hemodynamic Monitoring and Therapy

University of York
2021-2025

Hull York Medical School
2021-2025

Velindre NHS Trust
2023-2024

Al-Quds University
2023

Duke Medical Center
2023

University of Central Lancashire
2022

The widespread adoption of the frozen elephant trunk (FET) technique for total arch reconstruction (TAR) in aortic aneurysm and dissection has led to development numerous commercial single-piece FET devices, each with its own unique design features. One such device, Thoraflex™ Hybrid (Terumo Aortic, Glasgow, Scotland), enjoyed use since introduction. We present appraisal long-term clinical efficacy, based on international data.Pre-, intra-, postoperative data associated implantations...

10.3389/fcvm.2022.842165 article EN cc-by Frontiers in Cardiovascular Medicine 2022-02-22

Abstract Introduction The frozen elephant trunk (FET) procedure remains the mainstay treatment for managing complex aortic pathologies due to its ability minimise necessity second-stage surgeries. technique utilises hybrid prostheses, and although Thoraflex E-vita have demonstrated favourable outcomes, much less is known about Cronus Frozenix-J. This systematic review aims evaluate efficacy of main FET prostheses. Methods A comprehensive search major databases was performed, relevant studies...

10.1093/bjs/znaf042.078 article EN other-oa British journal of surgery 2025-03-01

Surgical intervention remains the mainstay treatment for aortic arch aneurysm and dissection, but high mortality morbidity rates have led to a need development of minimally invasive alternatives reconstruction. RELAY™ Branched (Terumo Aortic, Inchinnan, UK) represents viable option complex endovascular repair. We present multi-center data from Europe documenting efficacy endograft in terms its target vessel patency reintervention rates. Prospective collected between January 2019 2022...

10.3389/fcvm.2022.962884 article EN cc-by Frontiers in Cardiovascular Medicine 2022-06-29

While open surgical repair continues to be the mainstay option for aortic arch reconstruction, associated mortality, morbidity, and high turn-down rates have led a need development of minimally invasive options repair. Though RELAY™ Branched (Terumo Aortic, Inchinnan, UK) represents promising complex endovascular repair, neurological complications remain pertinent risk. Herein we seek present multicenter data from Europe documenting outcomes with Branched.Prospective collected between...

10.1111/jocs.16957 article EN Journal of Cardiac Surgery 2022-09-19

Background The high mortality and morbidity rates in surgical aortic arch repair are a barrier to therapy for considerable proportion of patients with aneurysm or dissection. There is hence demand the development adoption minimally invasive alternative repair, such as thoracic endovascular (TEVAR). Procedural duration key factor pathogenesis complications repair. Herein, we evaluate whether impacts neurological outcomes, target vessel patency, reintervention TEVAR RELAY™ Branched (Terumo...

10.3389/fcvm.2022.969858 article EN cc-by Frontiers in Cardiovascular Medicine 2022-07-18
Coming Soon ...